July 7, 2025: Laurus Labs Share Price – Shares of Laurus Labs Ltd. continued to demonstrate robust momentum, trading at ₹769.7 as of the latest session. The midcap pharmaceutical company, listed on the BSE, has witnessed a phenomenal rise of over 60% in the past year, reflecting investor confidence in its strategic direction and earnings outlook.
On Monday, the stock fluctuated between ₹763.4 and ₹778.55, slightly off its 52-week high of ₹777.9. In the short term, Laurus Labs delivered a weekly return of 8.94%, while posting gains of 20.25% over the past month and an impressive 37.44% rally over the past three months.
From a technical standpoint, Laurus Labs shows strength with its current price near its daily pivot of ₹770.1. The stock faces immediate resistance at ₹774.6 and ₹783.05, while support is expected at ₹761.65 and ₹757.15. Notably, both short-term and long-term moving averages signal bullish trends, with the 5-day EMA at ₹750.43 and 200-day EMA at ₹580.26.
Performance across broader timeframes also paints a positive picture. The stock has surged 27.46% in six months, while its three-year return stands at 65%, and five-year return at an impressive 598.45% — underscoring its strong long-term growth potential.
In comparison, sector giant Sun Pharmaceutical Industries has seen relatively flat movement, returning -1.29% over the past week and just 6.21% over the last year.
As Laurus Labs continues to outperform many of its peers in the pharmaceuticals sector, investor sentiment remains optimistic, especially with strong fundamentals and technical support levels intact.